國立成功大學醫學系醫學士2013~2019

和信治癌中心醫院 腫瘤內科部專研醫師2023~2026.
和信治癌中心醫院 內科部住院醫師PGY 2021~2023.
和信治癌中心醫院 內科部不分科住院醫師PGY 2019~2021. 
 

中華民國內科醫學會、中華民國癌症醫學會、中華民國血液病學會。

1. Lin HT, Huang CJ. The Use of High-Flow Nasal Oxygen in Cancer Patients. Resuscitation & Intensive Care Med. 2023;8:37-42.
2. Lin HT, Chiou LW, Chu NM, et al. Impact of Early versus Delayed G-CSF Administration on Clinical Outcomes in Chemotherapy-induced Neutropenia: A Propensity Score-matching Cohort Study. J Cancer Res Pract. 2026. DOI:10.4103/ejcrp.ejcrp-d-25-00039.
3. Lin HT, Tan TD, Chiou LW. The Impact of Hematopoietic Stem Cell Transplantation to Overall Survival in T Cell Lymphoma: A Single-center Experience. EHA Library. 2024; 421848; PB3082.
4. Lin HT, Hou TY. Readable Minds: Emergent Theory-of-Mind-Like Behavior in LLM Poker Agents. arXiv. 2026.
5. 第182次聯合學術研討會 (2023-10-13) Nephrotic syndrome after hematopoietic stem cell transplantation. (投稿人：譚傳德；報告人：林協霆)
6. 第183次聯合學術研討會(2024-01-15) Real-world Outcome of the Impact of Hematopoietic Stem Cell Transplant on the Treatment of Peripheral T-Cell Lymphoma. (報告人：林協霆)
7. 第186次聯合學術研討會(2025-01-12) The Outcome of Salvage Second or More Hematopoietic Stem Cell Transplantations in Late Relapsed Patients is not Inferior to a Single Transplant in Hematologic Patients - 20 Years of Experience in a Single Institute. (報告人：林協霆)
8. 第189次聯合學術研討會(2026-01-30) IT-MTX Prophylaxis in DLBCL-A Competing Risks Analysis of Secondary CNS Lymphoma Prevention. (投稿人/報告人：林協霆)